EV/EBITDA:
-9.27-0.85(-10.10%)Summary
- As of today (September 18, 2025), VKTX EV/EBITDA is -9.27, with a fall of -0.85 (-10.10%) during the current trading session.
- Over the past year, VKTX EV/EBITDA has increased by +40.57 (+81.40%).
- VKTX EV/EBITDA is now -2748.57% below its all-time high of 0.35.
Performance
VKTX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
VKTX EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -10.1% | +10.0% | +6.9% |
| 1 m1 month | +49.8% | -49.9% | -41.4% |
| 3 m3 months | +24.1% | -6.3% | -6.1% |
| 6 m6 months | +42.0% | -18.2% | -16.2% |
| ytdytd | +61.1% | -45.1% | -38.7% |
| 1 y1 year | +81.4% | -68.2% | -61.7% |
| 5 y5 years | -43.9% | +737.2% | +260.9% |
VKTX EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -8.42 | -10.1% | -18.48 | +49.8% |
| 3 m | 3-month | -8.42 | -10.1% | -18.48 | +49.8% |
| 6 m | 6-month | -8.10 | -14.4% | -18.48 | +49.8% |
| 1 y | 1-year | -8.10 | -14.4% | -58.10 | +84.0% |
| 3 y | 3-year | -0.47 | -1872.3% | -95.77 | +90.3% |
| 5 y | 5-year | 0.35 | -2748.6% | -95.77 | +90.3% |
| alltime | all time | 0.35 | -2748.6% | -95.77 | +90.3% |
VKTX EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -9.27(-61.1%) |
| 2024 | -23.83(+59.5%) |
| 2023 | -14.94(+80.0%) |
| Date | Value |
|---|---|
| 2022 | -8.30(+191.2%) |
| 2021 | -2.85(-28.2%) |
| 2020 | -3.97 |
FAQ
- What is Viking Therapeutics, Inc. EV/EBITDA?
- What is the all time high EV/EBITDA for Viking Therapeutics, Inc.?
- What is VKTX EV/EBITDA year-to-date change?
- What is Viking Therapeutics, Inc. EV/EBITDA year-on-year change?
What is Viking Therapeutics, Inc. EV/EBITDA?
The current EV/EBITDA of VKTX is -9.27
What is the all time high EV/EBITDA for Viking Therapeutics, Inc.?
Viking Therapeutics, Inc. all-time high EV/EBITDA is 0.35
What is VKTX EV/EBITDA year-to-date change?
Viking Therapeutics, Inc. EV/EBITDA has changed by +14.56 (+61.10%) since the beginning of the year
What is Viking Therapeutics, Inc. EV/EBITDA year-on-year change?
Over the past year, VKTX EV/EBITDA has changed by +40.57 (+81.40%)